I
Immunic D
D
IMUX
1.12500
USD
0.05
(4.17%)
مغلق
حجم التداول
22,897
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
107,794,728
الأخبار المقالات
العنوان: Immunic
القطاع: Healthcare
الصناعة: Biotechnology
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.